• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

坚守或打破药代动力学中的叠加定律

Upholding or Breaking the Law of Superposition in Pharmacokinetics.

作者信息

Yousef Malaz, Yáñez Jaime A, Löbenberg Raimar, Davies Neal M

机构信息

Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2E1, Canada.

Escuela de Posgrado, Universidad Internacional Iberoamericana, Campeche 24560, Mexico.

出版信息

Biomedicines. 2024 Aug 13;12(8):1843. doi: 10.3390/biomedicines12081843.

DOI:10.3390/biomedicines12081843
PMID:39200307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11351987/
Abstract

The law of superposition underpins first-order linear pharmacokinetic relationships. Most drugs, therefore, after a single dose can be described by first-order or linear processes, which can be superposed to understand multiple-dose regimen behavior. However, there are a number of situations where drugs could display behaviors after multiple dosing that leads to capacity-limited or saturation non-linear kinetics and the law of superposition is overruled. This review presents a practical guide to understand the equations and calculations for single and multiple-dosing regimens after intravenous and oral administration. It also provides the pharmaceutical basis for saturation in ADME processes and the consequent changes in the area under the concentration-time curve, which represents drug exposure that can lead to the modulation of efficacy and/or toxic effects. The pharmacokineticist must implicitly understand the principles of superposition, which are a central tenet of drug behavior and disposition during drug development.

摘要

叠加原理是一级线性药代动力学关系的基础。因此,大多数药物在单次给药后可用一级或线性过程来描述,这些过程可以叠加起来以理解多剂量给药方案的行为。然而,在许多情况下,药物在多次给药后可能会表现出导致容量受限或饱和非线性动力学的行为,叠加原理不再适用。本综述提供了一份实用指南,以理解静脉注射和口服给药后单剂量和多剂量给药方案的方程和计算。它还提供了药物在吸收、分布、代谢和排泄(ADME)过程中饱和的药学基础,以及由此导致的浓度-时间曲线下面积的变化,该面积代表药物暴露,可导致疗效和/或毒性作用的调节。药代动力学家必须深入理解叠加原理,这是药物研发过程中药物行为和处置的核心原则。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6601/11351987/f77b827cfd30/biomedicines-12-01843-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6601/11351987/6f8726d7814c/biomedicines-12-01843-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6601/11351987/0241defdcd5f/biomedicines-12-01843-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6601/11351987/67069bc59772/biomedicines-12-01843-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6601/11351987/54412d485488/biomedicines-12-01843-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6601/11351987/f77b827cfd30/biomedicines-12-01843-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6601/11351987/6f8726d7814c/biomedicines-12-01843-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6601/11351987/0241defdcd5f/biomedicines-12-01843-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6601/11351987/67069bc59772/biomedicines-12-01843-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6601/11351987/54412d485488/biomedicines-12-01843-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6601/11351987/f77b827cfd30/biomedicines-12-01843-g005.jpg

相似文献

1
Upholding or Breaking the Law of Superposition in Pharmacokinetics.坚守或打破药代动力学中的叠加定律
Biomedicines. 2024 Aug 13;12(8):1843. doi: 10.3390/biomedicines12081843.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
Anterior Approach Total Ankle Arthroplasty with Patient-Specific Cut Guides.使用患者特异性截骨导向器的前路全踝关节置换术。
JBJS Essent Surg Tech. 2025 Aug 15;15(3). doi: 10.2106/JBJS.ST.23.00027. eCollection 2025 Jul-Sep.
5
Sexual Harassment and Prevention Training性骚扰与预防培训
6
Short-Term Memory Impairment短期记忆障碍
7
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
8
Thrombolysis for acute ischaemic stroke.急性缺血性脑卒中的溶栓治疗
Cochrane Database Syst Rev. 2003(3):CD000213. doi: 10.1002/14651858.CD000213.
9
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.
10
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.

引用本文的文献

1
Correction: Yousef et al. Upholding or Breaking the Law of Superposition in Pharmacokinetics. 2024, , 1843.更正:优素福等人。在药代动力学中遵循或打破叠加定律。2024年,第1843页。
Biomedicines. 2025 Jul 23;13(8):1797. doi: 10.3390/biomedicines13081797.
2
Double Peaking Phenomena in Pharmacokinetic Disposition Revisited.重新审视药代动力学处置中的双峰现象。
Clin Pharmacokinet. 2025 Aug 13. doi: 10.1007/s40262-025-01559-4.
3
Formulation Strategy of BCS-II Drugs by Coupling Mechanistic In-Vitro and Nonclinical In-Vivo Data with PBPK: Fundamentals of Absorption-Dissolution to Parameterization of Modelling and Simulation.

本文引用的文献

1
The Lymphatic System: A Sometimes-Forgotten Compartment in Pharmaceutical Sciences.淋巴系统:药物科学中一个时常被忽视的领域。
J Pharm Pharm Sci. 2021;24:533-547. doi: 10.18433/jpps32222.
2
Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Benfotiamine in Healthy Subjects.健康受试者单次及多次递增剂量服用苯磷硫胺的安全性、耐受性和药代动力学
Drug Des Devel Ther. 2021 Mar 9;15:1101-1110. doi: 10.2147/DDDT.S296197. eCollection 2021.
3
Combatting the Rising Tide of Antimicrobial Resistance: Pharmacokinetic/Pharmacodynamic Dosing Strategies for Maximal Precision.
通过将体外机制性数据和非临床体内数据与生理药代动力学(PBPK)相结合来制定BCS-II类药物的策略:从吸收-溶出基础到建模与模拟的参数化
AAPS PharmSciTech. 2025 Apr 17;26(5):106. doi: 10.1208/s12249-025-03093-9.
4
Which Models are USEful?哪些模型是有用的?
Pharm Res. 2024 Dec;41(12):2271-2274. doi: 10.1007/s11095-024-03799-8. Epub 2024 Dec 2.
对抗日益严重的抗微生物药物耐药性:最大精度的药代动力学/药效学给药策略。
Int J Antimicrob Agents. 2021 Mar;57(3):106269. doi: 10.1016/j.ijantimicag.2020.106269. Epub 2020 Dec 23.
4
A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers.健康志愿者中菲玛沙坦和利纳格列汀的药代动力学药物相互作用。
Drug Des Devel Ther. 2020 May 26;14:2101-2111. doi: 10.2147/DDDT.S248205. eCollection 2020.
5
An Assessment of Pharmacokinetic Interaction Between Lobeglitazone and Sitagliptin After Multiple Oral Administrations in Healthy Men.健康男性多次口服洛格列酮和西他列汀的药代动力学相互作用评估。
Clin Ther. 2020 Jun;42(6):1047-1057. doi: 10.1016/j.clinthera.2020.04.005. Epub 2020 Apr 30.
6
Clinical Pharmacokinetics of Propranolol Hydrochloride: A Review.盐酸普萘洛尔的临床药代动力学:综述。
Curr Drug Metab. 2020;21(2):89-105. doi: 10.2174/1389200221666200414094644.
7
Pharmacokinetic/pharmacodynamic adequacy of polymyxin B against extensively drug-resistant Gram-negative bacteria in critically ill, general ward and cystic fibrosis patient populations.多黏菌素 B 对重症、普通病房和囊性纤维化患者人群中广泛耐药革兰氏阴性菌的药代动力学/药效学适宜性。
Int J Antimicrob Agents. 2020 Jun;55(6):105943. doi: 10.1016/j.ijantimicag.2020.105943. Epub 2020 Mar 15.
8
Safety, Pharmacokinetics, and Food Effect of Tebipenem Pivoxil Hydrobromide after Single and Multiple Ascending Oral Doses in Healthy Adult Subjects.替比培南匹伏酯氢溴酸盐在健康成年受试者中单次和多次递增口服给药的安全性、药代动力学和食物影响。
Antimicrob Agents Chemother. 2019 Aug 23;63(9). doi: 10.1128/AAC.00618-19. Print 2019 Sep.
9
Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets.阿托伐他汀和二甲双胍固定剂量复方制剂与单方片剂的药代动力学比较。
Drug Des Devel Ther. 2019 May 13;13:1623-1632. doi: 10.2147/DDDT.S193254. eCollection 2019.
10
Therapeutic novelties in migraine: new drugs, new hope?偏头痛的治疗新进展:新药,新希望?
J Headache Pain. 2019 Apr 17;20(1):37. doi: 10.1186/s10194-019-0974-3.